Caribou Biosciences at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Caribou Biosciences exhibits at Booth 513 at ASH 2026 in New Orleans. Caribou Biosciences supports a symposium on CAR-T cell therapy for lymphoma, run by PeerView Institute for Medical Education. Its expert workshops cover current CAR-T standards, where the therapy fits in the treatment sequence and emerging cellular therapy platforms.
| Organization | ASH 2026 Attendance |
|---|---|
Caribou Biosciences Berkeley, CA | |
Clinical-stage CRISPR genome-editing company developing off-the-shelf allogeneic CAR-T cell therapies for blood cancers. | Booth Exhibiting at Booth 513 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Symposium Fri Dec 11 7:00pm–10:00pm Accelerating CARs for Lymphoma: Expert Workshops on CAR-T Standards, Sequencing, and Emerging Cellular Therapy Platforms CAR-T as standard lymphoma care and what comes next, including dual-target, faster-manufactured, and in vivo versions that could widen patient access. |
Instantly find 20 buyers from Caribou Biosciences
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction